{"id":7117,"date":"2018-03-09T10:01:46","date_gmt":"2018-03-09T07:01:46","guid":{"rendered":"http:\/\/prodiab.md\/?p=7117"},"modified":"2018-03-09T10:02:03","modified_gmt":"2018-03-09T07:02:03","slug":"aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2","status":"publish","type":"post","link":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/","title":{"rendered":"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2!"},"content":{"rendered":"<p><strong>Pentru persoanele care tr\u0103iesc cu diabet tip2 \u015fi cu insuficien\u0163\u0103 cardiac\u0103, o aspirin\u0103 pe zi le reduce riscul de a muri sau de a fi spitaliza\u0163i cu infarct miocardic, conform unor cercet\u0103ri prezentate la cel mai recent congres de cardiologie american. Dar acelea\u015fi date spun c\u0103 aspirina cre\u015fte riscul de boli de inim\u0103 nonfatale \u015fi de atac cerebral, aceste rezultate contradictorii fiind o surpriz\u0103 pentru cercet\u0103tori.<\/strong><\/p>\n<p>Acest studiu este primul care ia \u00een considerare\u00a0aspirina\u00a0ca metod\u0103 de preven\u0163ie pentru pacien\u0163ii care sufer\u0103 at\u00e2t de diabet c\u00e2t \u015fi de probleme cardiace.\u00a0<strong>Aspirina<\/strong>, un medicament care sub\u0163iaz\u0103 s\u00e2ngele\u00a0<strong>este recomandat\u0103 pacien\u0163ilor care au suferit un atac de cord sau atac cerebral<\/strong>, dar protocoalele medicale nu sunt foarte clare c\u00e2nd vine vorba despre pacien\u0163ii cu risc cardiovascular, dar care nu au suferit un atac de cord sau un atac cerebral.<\/p>\n<p>Aproximativ 27 de milioane de americani au diabet tip2 \u015fi \u00een jur de 6,5 milioane de adul\u0163i sufer\u0103 de insuficien\u0163\u0103 cardiac\u0103, o afec\u0163iune \u00een urma c\u0103reia inima devine prea sl\u0103bit\u0103 pentru a pompa s\u00e2ngele necesar func\u0163ion\u0103rii \u00eentregului organism. Ambele afec\u0163iuni sunt asociate cu un risc cardiac crescut, inclusiv de infarct \u015fi atac cerebral. Acest studiu aduce informa\u0163ii noi pentru pacien\u0163ii care sufer\u0103 de ambele afec\u0163iuni.<\/p>\n<p>\u201e<strong>Am fost surprin\u015fi s\u0103 observ\u0103m cre\u015fterea paradoxal\u0103 a infarcturilor miocardice \u015fi a atacurilor cerebrale nonfatale, paralel cu o descre\u015ftere a ratei mortalit\u0103\u0163ii la pacien\u0163i cu diabet \u015fi afec\u0163iuni cardiace,\u201d\u00a0<\/strong>spune Charbel Abi Khalil, conduc\u0103torul studiului, profesor la Weill Cornell Medicine-Qatar.<\/p>\n<p>\u00cen studiu s-au folosit informa\u0163ii dintr-o baz\u0103 de date britanic\u0103, de unde s-au extras dosarele medicale a peste 12.000 de pacien\u0163i cu v\u00e2rsta de peste 55 de ani \u015fi care sufereau de diabet de tip 2 \u015fi insuficien\u0163\u0103 cardiac\u0103, dar nu aveau istoric de infarct, atac cerebral, fibrila\u0163ie atrial\u0103. La o jum\u0103tate dintre ei li s-a prescris o\u00a0aspirin\u0103 pe zi\u00a0\u015fi la cealalt\u0103 jum\u0103tate, nu.<\/p>\n<p>Cercet\u0103torii au analizat rezultatele dup\u0103 cinci ani \u00een care ace\u015fti pacien\u0163i au fost monitoriza\u0163i. Toate cazurile de mortalitate \u015fi spitalizare pentru insuficien\u0163a cardiac\u0103 au fost urm\u0103rite ca un rezultat principal. Toate cazurile de mortalitate, spitalizare pentru insuficien\u0163\u0103 cardiac\u0103, evenimente hemoragice majore \u015fi infarct miocardic sau accident vascular cerebral au fost urm\u0103rite separat ca rezultate secundare. Cei care au luat o aspirina zilnica au avut o sc\u0103dere de 10% \u00een rezultatul primar, cu nicio diferen\u0163a \u00een evenimentele hemoragice majore, precum \u015fi o cre\u015ftere de 50 % \u00een infarct miocardic sau accident vascular cerebral.<\/p>\n<p><strong>Aspirina interfereaz\u0103 cu capacitatea s\u00e2ngelui de a se coagula,<\/strong>\u00a0prin reducerea activit\u0103\u0163ii trombocitelor, care se agreg\u0103 \u00een timpul form\u0103rii cheagurilor. Insuficien\u0163a cardiac\u0103 \u015fi diabetul provoac\u0103 modific\u0103ri ale s\u00e2ngelui, ceea ce face ca formarea cheagurilor s\u0103 fie mai probabil\u0103, motiv pentru care aceste afec\u0163iuni sunt asociate cu un risc mai mare de atacuri de cord \u015fi accidente vasculare cerebrale. &#8222;At\u00e2t\u00a0<strong>insuficien\u0163a cardiac\u0103, c\u00e2t \u015fi diabetul zaharat sunt asociate cu cre\u015fterea activit\u0103\u0163ii de coagulare a s\u00e2ngelui<\/strong>\u00a0&#8222;, a spus Abi Khalil. Deoarece reduce scleroza agreg\u0103rii plachetare, aspirina este considerata a sc\u0103dea probabilitatea formarii cheagurilor de s\u00e2nge d\u0103un\u0103toare, cum ar fi cele responsabile pentru infarct miocardic si accident vascular cerebral.<\/p>\n<p>Abi Khalil este de p\u0103rere c\u0103 pacien\u0163ii ar trebui sa vorbeasc\u0103 cu medicii lor pentru a evalua beneficiile si riscurile de a lua aspirina.<\/p>\n<p>Sursa:\u00a0 www.csid.ro<\/p>","protected":false},"excerpt":{"rendered":"<p>Pentru persoanele care tr\u0103iesc cu diabet tip2 \u015fi cu insuficien\u0163\u0103 cardiac\u0103, o aspirin\u0103 pe zi le reduce riscul de a muri sau de a fi spitaliza\u0163i cu infarct miocardic, conform unor cercet\u0103ri prezentate la cel mai recent congres de cardiologie american. Dar acelea\u015fi date spun c\u0103 aspirina cre\u015fte riscul de boli de inim\u0103 nonfatale \u015fi&#8230;<\/p>\n","protected":false},"author":3,"featured_media":7118,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0},"categories":[5],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.5.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2! - PRODIAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2! - PRODIAB\" \/>\n<meta property=\"og:description\" content=\"Pentru persoanele care tr\u0103iesc cu diabet tip2 \u015fi cu insuficien\u0163\u0103 cardiac\u0103, o aspirin\u0103 pe zi le reduce riscul de a muri sau de a fi spitaliza\u0163i cu infarct miocardic, conform unor cercet\u0103ri prezentate la cel mai recent congres de cardiologie american. Dar acelea\u015fi date spun c\u0103 aspirina cre\u015fte riscul de boli de inim\u0103 nonfatale \u015fi...\" \/>\n<meta property=\"og:url\" content=\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/\" \/>\n<meta property=\"og:site_name\" content=\"PRODIAB\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-09T07:01:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-09T07:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"358\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valeriu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"http:\/\/prodiab.md\/ro\/#organization\",\"name\":\"Asocia\u0163ia Diabeticilor din Republica Moldova\",\"url\":\"http:\/\/prodiab.md\/ro\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"http:\/\/prodiab.md\/ro\/#logo\",\"inLanguage\":\"ro-RO\",\"url\":\"http:\/\/prodiab.md\/wp-content\/uploads\/2014\/06\/logo_test11.png\",\"contentUrl\":\"http:\/\/prodiab.md\/wp-content\/uploads\/2014\/06\/logo_test11.png\",\"width\":227,\"height\":69,\"caption\":\"Asocia\u0163ia Diabeticilor din Republica Moldova\"},\"image\":{\"@id\":\"http:\/\/prodiab.md\/ro\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/prodiab.md\/ro\/#website\",\"url\":\"http:\/\/prodiab.md\/ro\/\",\"name\":\"PRODIAB\",\"description\":\"Asociatia Diabeticilor din Republica Moldova &quot;PRODIAB&quot;\",\"publisher\":{\"@id\":\"http:\/\/prodiab.md\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/prodiab.md\/ro\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"ImageObject\",\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#primaryimage\",\"inLanguage\":\"ro-RO\",\"url\":\"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg\",\"contentUrl\":\"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg\",\"width\":650,\"height\":358},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#webpage\",\"url\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/\",\"name\":\"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2! - PRODIAB\",\"isPartOf\":{\"@id\":\"http:\/\/prodiab.md\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#primaryimage\"},\"datePublished\":\"2018-03-09T07:01:46+00:00\",\"dateModified\":\"2018-03-09T07:02:03+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[[\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/\"]]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0413\u043b\u0430\u0432\u043d\u043e\u0435 \u043c\u0435\u043d\u044e\",\"item\":\"http:\/\/prodiab.md\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2!\"}]},{\"@type\":\"Article\",\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#webpage\"},\"author\":{\"@id\":\"http:\/\/prodiab.md\/#\/schema\/person\/72f467abbf97f9a8c159dc5343c93573\"},\"headline\":\"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2!\",\"datePublished\":\"2018-03-09T07:01:46+00:00\",\"dateModified\":\"2018-03-09T07:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#webpage\"},\"wordCount\":613,\"publisher\":{\"@id\":\"http:\/\/prodiab.md\/#organization\"},\"image\":{\"@id\":\"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg\",\"articleSection\":[\"\u015eTIRI\"],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/prodiab.md\/#\/schema\/person\/72f467abbf97f9a8c159dc5343c93573\",\"name\":\"Valeriu\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"http:\/\/prodiab.md\/ro\/#personlogo\",\"inLanguage\":\"ro-RO\",\"url\":\"http:\/\/0.gravatar.com\/avatar\/f1d1301a66e5940b7bfe515b5fdec235?s=96&d=mm&r=g\",\"contentUrl\":\"http:\/\/0.gravatar.com\/avatar\/f1d1301a66e5940b7bfe515b5fdec235?s=96&d=mm&r=g\",\"caption\":\"Valeriu\"},\"url\":\"http:\/\/prodiab.md\/ro\/author\/valeriu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2! - PRODIAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/","og_locale":"ro_RO","og_type":"article","og_title":"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2! - PRODIAB","og_description":"Pentru persoanele care tr\u0103iesc cu diabet tip2 \u015fi cu insuficien\u0163\u0103 cardiac\u0103, o aspirin\u0103 pe zi le reduce riscul de a muri sau de a fi spitaliza\u0163i cu infarct miocardic, conform unor cercet\u0103ri prezentate la cel mai recent congres de cardiologie american. Dar acelea\u015fi date spun c\u0103 aspirina cre\u015fte riscul de boli de inim\u0103 nonfatale \u015fi...","og_url":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/","og_site_name":"PRODIAB","article_published_time":"2018-03-09T07:01:46+00:00","article_modified_time":"2018-03-09T07:02:03+00:00","og_image":[{"width":650,"height":358,"url":"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg","type":"image\/jpeg"}],"twitter_card":"summary","twitter_misc":{"Scris de":"Valeriu","Timp estimat pentru citire":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"http:\/\/prodiab.md\/ro\/#organization","name":"Asocia\u0163ia Diabeticilor din Republica Moldova","url":"http:\/\/prodiab.md\/ro\/","sameAs":[],"logo":{"@type":"ImageObject","@id":"http:\/\/prodiab.md\/ro\/#logo","inLanguage":"ro-RO","url":"http:\/\/prodiab.md\/wp-content\/uploads\/2014\/06\/logo_test11.png","contentUrl":"http:\/\/prodiab.md\/wp-content\/uploads\/2014\/06\/logo_test11.png","width":227,"height":69,"caption":"Asocia\u0163ia Diabeticilor din Republica Moldova"},"image":{"@id":"http:\/\/prodiab.md\/ro\/#logo"}},{"@type":"WebSite","@id":"http:\/\/prodiab.md\/ro\/#website","url":"http:\/\/prodiab.md\/ro\/","name":"PRODIAB","description":"Asociatia Diabeticilor din Republica Moldova &quot;PRODIAB&quot;","publisher":{"@id":"http:\/\/prodiab.md\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/prodiab.md\/ro\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ro-RO"},{"@type":"ImageObject","@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#primaryimage","inLanguage":"ro-RO","url":"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg","contentUrl":"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg","width":650,"height":358},{"@type":"WebPage","@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#webpage","url":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/","name":"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2! - PRODIAB","isPartOf":{"@id":"http:\/\/prodiab.md\/ro\/#website"},"primaryImageOfPage":{"@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#primaryimage"},"datePublished":"2018-03-09T07:01:46+00:00","dateModified":"2018-03-09T07:02:03+00:00","breadcrumb":{"@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":[["http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/"]]}]},{"@type":"BreadcrumbList","@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0413\u043b\u0430\u0432\u043d\u043e\u0435 \u043c\u0435\u043d\u044e","item":"http:\/\/prodiab.md\/ro\/"},{"@type":"ListItem","position":2,"name":"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2!"}]},{"@type":"Article","@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#article","isPartOf":{"@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#webpage"},"author":{"@id":"http:\/\/prodiab.md\/#\/schema\/person\/72f467abbf97f9a8c159dc5343c93573"},"headline":"Aspirina scade riscul de moarte timpurie la pacien\u021bii cu diabet zaharat de tip 2!","datePublished":"2018-03-09T07:01:46+00:00","dateModified":"2018-03-09T07:02:03+00:00","mainEntityOfPage":{"@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#webpage"},"wordCount":613,"publisher":{"@id":"http:\/\/prodiab.md\/#organization"},"image":{"@id":"http:\/\/prodiab.md\/ro\/aspirina-scade-riscul-de-moarte-timpurie-la-pacientii-cu-diabet-zaharat-de-tip-2\/#primaryimage"},"thumbnailUrl":"http:\/\/prodiab.md\/wp-content\/uploads\/2018\/03\/media-147893667777324700.jpg","articleSection":["\u015eTIRI"],"inLanguage":"ro-RO"},{"@type":"Person","@id":"http:\/\/prodiab.md\/#\/schema\/person\/72f467abbf97f9a8c159dc5343c93573","name":"Valeriu","image":{"@type":"ImageObject","@id":"http:\/\/prodiab.md\/ro\/#personlogo","inLanguage":"ro-RO","url":"http:\/\/0.gravatar.com\/avatar\/f1d1301a66e5940b7bfe515b5fdec235?s=96&d=mm&r=g","contentUrl":"http:\/\/0.gravatar.com\/avatar\/f1d1301a66e5940b7bfe515b5fdec235?s=96&d=mm&r=g","caption":"Valeriu"},"url":"http:\/\/prodiab.md\/ro\/author\/valeriu\/"}]}},"_links":{"self":[{"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/posts\/7117"}],"collection":[{"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/comments?post=7117"}],"version-history":[{"count":2,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/posts\/7117\/revisions"}],"predecessor-version":[{"id":7120,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/posts\/7117\/revisions\/7120"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/media\/7118"}],"wp:attachment":[{"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/media?parent=7117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/categories?post=7117"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/prodiab.md\/ro\/wp-json\/wp\/v2\/tags?post=7117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}